HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: jcp.2005.029215v1 59/4/396    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Agis, H Articles by Valent, P Search for Related Content PubMed PubMed Citation Articles by Agis, H Articles by Valent, P Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB HISTAMINE

Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7

¹ Department of Internal Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Austria
² Department of Clinical Pathology, Medical University of Vienna
³ Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology, Virginia Commonwealth University, Richmond, Virginia, USA
⁴ Children’s Cancer Research Institute, St Anna Children’s Hospital, Vienna, Austria
⁵ Department of Pathology, University of Lübeck, Germany

Correspondence to:
Dr Peter Valent
Department of Internal Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria; peter.valent{at}meduniwien.ac.at Background: Basophils are highly specialised granulocytes that express a unique profile of antigens and increase in myeloproliferative disorders (MPD). In chronic myeloid leukaemia (CML), basophilia is a diagnostic and prognostic determinant. So far, however, no reliable approach for routine detection and enumeration of bone marrow basophils has become available.

Objective: To detect and enumerate basophils in bone marrow sections in patients with CML and other MPD

Methods: The anti-basophil antibody 2D7 was applied to paraffin embedded bone marrow sections from normal/reactive subjects (n = 31), patients with CML (chronic phase, n = 37; accelerated phase, n = 9), and other MPD (chronic idiopathic myelofibrosis (CIMF), n = 20; polycythaemia vera (PV), n = 20; essential thrombocythaemia (ET), n = 20; indolent systemic mastocytosis (ISM), n = 7).

Results: As assessed by serial section staining, 2D7⁺ cells were found to co-express myeloperoxidase, histidine decarboxylase, CD9, and CD43, but did not express B cell or T cell restricted antigens. 2D7⁺ bone marrow cells were found to increase in CML compared with normal/reactive bone marrow and other MPD (median numbers of 2D7⁺ cells/mm²: CML, 33; normal/reactive bone marrow, 6; CIMF, 10; PV, 6; ET, 5; ISM, 3; p<0.05). The highest basophil counts were recorded in accelerated phase CML (115/mm²).

Conclusions: A novel immunohistochemical procedure has been established for basophil detection in normal bone marrow and MPD. This approach should help in the quantification of bone marrow basophils at diagnosis and during anti-leukaemic treatment.

Abbreviations: CIMF, chronic idiopathic myelofibrosis; CML, chronic myeloid leukaemia; MPD, myeloproliferative disorder; VEGF, vascular endothelial growth factor

Keywords: basophil; chronic myeloid leukaemia; immunohistochemistry; myeloproliferative diseases

This article has been cited by other articles:

				K. J. Aichberger, M. Mayerhofer, A. Vales, M.-T. Krauth, K. V. Gleixner, M. Bilban, H. Esterbauer, K. Sonneck, S. Florian, S. Derdak, et al. The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells Blood, November 15, 2006; 108(10): 3538 - 3547. [Abstract] [Full Text] [PDF]